Bonacchi Massimo, Ciapetti Marco, Di Lascio Gabriella, Harmelin Guy, Sani Guido, Peris Adriano
Interv Med Appl Sci. 2013 Dec;5(4):186-92. doi: 10.1556/IMAS.5.2013.4.7. Epub 2013 Dec 20.
The novel pandemic influenza A (H1N1) caused an epidemic of critical illness, and some patients developed severe acute respiratory distress syndrome (ARDS) or severe cardiopulmonary failure despite the use of conventional management. Extracorporeal membrane oxygenation (ECMO) support may successfully rescue these severely ill patients. We demonstrate the causative role of H1N1 in refractory ARDS of a previously healthy 15-year-old man who presented to the intensive care unit with a hypoxic and persistent cardiogenic shock refractory to conventional management as the leading symptom of influenza A. Because of compromised cardiopulmonary function, venovenous ECMO was applied 24 h after admission. Despite that the patient was manifesting heart failure, we decided the placement of venovenous ECMO because we believed that the real problem was the uncontrollable hypoxia and hypercapnia. A normal left ventricular ejection fraction was documented on a 2D echocardiography on day 2. The patient, after 6 days of ECMO, recovered completely and was successfully weaned from the mechanical ventilator on the 9th day after admission. The patient was discharged from the hospital on the 15th day. This experience showed that ECMO can be lifesaving for severe H1N1 infection also in patients with atypical clinical presentation of influenza.
新型甲型H1N1流感引发了重症疫情,尽管采用了传统治疗方法,仍有部分患者发展为严重急性呼吸窘迫综合征(ARDS)或严重心肺功能衰竭。体外膜肺氧合(ECMO)支持可能成功挽救这些重症患者。我们证明了H1N1在一名先前健康的15岁男性难治性ARDS中的致病作用,该患者以缺氧和持续性心源性休克为主要症状入住重症监护病房,对传统治疗无效,而这是甲型流感的主要症状。由于心肺功能受损,入院24小时后应用了静脉-静脉ECMO。尽管患者表现出心力衰竭,但我们决定放置静脉-静脉ECMO,因为我们认为真正的问题是无法控制的缺氧和高碳酸血症。入院第2天的二维超声心动图显示左心室射血分数正常。患者在接受ECMO治疗6天后完全康复,并在入院后第9天成功脱机。患者于第15天出院。这一经验表明,对于流感临床表现不典型的患者,ECMO对严重H1N1感染也可挽救生命。